Flunafeb PR combines Flunarizine (10mg) and Propranolol (40mg), two effective medications used to manage and prevent migraine attacks. This combination enhances the efficacy of each drug by targeting different mechanisms involved in migraines. Flunarizine is a calcium channel blocker that helps reduce the dilation of blood vessels, thus preventing migraines. Propranolol, a beta-blocker, helps in reducing the frequency and severity of migraines by stabilizing blood pressure and calming the nervous system. Together, these active ingredients offer a synergistic approach to migraine prevention and management.

Flunafeb PR is widely used for the prophylaxis of migraine and the management of certain cardiovascular conditions like hypertension. It helps decrease the intensity and frequency of migraines, improving overall quality of life for patients. This medication can also help manage vertigo (dizziness) and is occasionally used for conditions involving irregular heart rhythms.

The combination of Flunarizine and Propranolol ensures that both vascular and nervous system components contributing to migraine attacks are addressed. While Flunarizine reduces the chances of vasodilation, Propranolol acts on the beta-adrenergic receptors to reduce hyperactivity, contributing to better control of the condition. For patients suffering from chronic migraines or frequent episodes, Flunafeb PR may offer significant relief and preventive benefits.

About the Product

Common side effects include dizziness, fatigue, nausea, and sleep disturbances. Serious side effects may include bradycardia (slow heart rate), hypotension (low blood pressure), or depression.

Flunafeb PR is indicated for the prevention of migraines, as well as for managing hypertension and preventing vertigo

Take Flunafeb PR exactly as prescribed. Discontinue only under a doctor's supervision, as abrupt cessation may trigger side effects.